Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
Karen Benn is a breast cancer advocate and survivor and has worked for Europa Donna for 13 years.
She is currently Head of Policy and Public Affairs for Europa Donna (ED). As such, she represents ED at a European level in many diverse fora and maintains and develops ED’s profile; she develops contacts with MEPs, the European Commission and other European bodies and helps keep ED’s advocacy initiatives to the fore. For example, she was instrumental in developing the European Parliament written declaration “On the Fight Against Breast Cancer in the European Union” (passed July 2015) and represents ED in many other EU initiatives such as CANCON, EPAAC, EUROCAN etc. Karen also runs ED’s annual Advocacy Training course, which has been running for 13 years. Karen is also in charge of membership for ED and researches and designs ED surveys such as on Genetic Testing for Hereditary Breast Cancer, Tissue Banking and Metastatic Breast Cancer. Karen is also closely involved in ED’s research agenda, and is on the steering committee of Breast International Group (BIG)’s AURORA progamme.